Roivant Sciences Ltd.
ROIV
Rank in Stocks
#978
Roivant Sciences Ltd. is a biopharmaceutical and healthcare technology company... Roivant Sciences Ltd. is a biopharmaceutical and healthcare technology company dedicated to discovering and advancing innovative therapeutic drugs. The firm's development pipeline targets a broad spectrum of diseases, including various forms of solid tumors and oncologic malignancies, hematological disorders like sickle cell disease and warm autoimmune hemolytic anemia, as well as rare conditions such as hypophosphatasia. Additionally, Roivant is developing treatments for immunological and dermatological ailments, including psoriasis, atopic dermatitis, vitiligo, hyperhidrosis, acne, myasthenia gravis, thyroid eye diseases, and sarcoidosis, alongside tackling infections like staph aureus bacteremia. Founded in 2014, its operations are based in London, United Kingdom.
Share Price
$33.73
Last synced: 2026-07-31
Market Cap
$24.37B
Change (1 day)
-2.28%
Change (1 year)
90.15%
Country
GB
Trade Roivant Sciences Ltd. (ROIV)
Category
Healthcare
Stock split history for Roivant Sciences Ltd. (ROIV)
Roivant Sciences Ltd. stock (symbol: ROIV) underwent a total of 0 stock splits.
The most recent stock split occurred on Oct 20, 2026.
One ROIV share bought prior to Oct 20, 2026 would equal to 0 ROIV shares today.
The most recent stock split occurred on Oct 20, 2026.
One ROIV share bought prior to Oct 20, 2026 would equal to 0 ROIV shares today.
Stock split list
| Year | Split | Multiple | Cumulative Multiple |
|---|---|---|---|
| Not enough data for the provided dates. | |||
Stock splits for similar companies or competitors
| Company | Number of stock splits | Cumulative Multiple | Country |
|---|---|---|---|
| 1 | x2 |
US
|
|
| 0 | - |
US
|
|
| 1 | x3 |
AU
|
|
| 0 | - |
CH
|
|
| 0 | - |
NL
|
